New app aims to keep pregnancy weight gain in check
NCT ID NCT05807594
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This study tests a digital platform called HMZ 2.0 that helps pregnant women with overweight or obesity manage their weight gain. 144 women will be randomly assigned to use the platform or receive standard pregnancy advice. The platform tracks weight, activity, and eating, and offers personalized coaching from a dietitian. The goal is to see if this approach can help women stay within healthy weight gain guidelines and improve outcomes for both mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pennsylvania State University
RECRUITINGUniversity Park, Pennsylvania, 16802, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital platform with personalized coaching and monitoring
What this could lead to
If successful, this could provide an effective, scalable tool to help pregnant women manage weight gain, potentially improving health outcomes for mothers and babies.
What could go wrong
This is a relatively small early-stage trial (144 participants), so results may not apply to all pregnant women. The intervention requires daily self-monitoring and weekly sessions, which may be burdensome.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.